{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T05:39:44Z","timestamp":1759815584069,"version":"3.37.3"},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Department of Urology and the Department of Radiology, University of Yamanashi"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,1]]},"DOI":"10.1093\/rheumatology\/keab138","type":"journal-article","created":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T20:07:20Z","timestamp":1612728440000},"page":"e255-e257","source":"Crossref","is-referenced-by-count":4,"title":["Disappearance of bilateral adrenal tumours: immunodeficiency-associated lymphoproliferative disorder in a patient with rheumatoid arthritis"],"prefix":"10.1093","volume":"60","author":[{"given":"Shunichiro","family":"Hanai","sequence":"first","affiliation":[{"name":"Third Department of Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8454-2170","authenticated-orcid":false,"given":"Kei","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, University of Yamanashi, Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Ichijo","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Nakagomi","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"key":"2021070122150135400_keab138-B1","first-page":"443","volume-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","author":"Gaulard","year":"2017","edition":"4th edn"},{"key":"2021070122150135400_keab138-B2","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/acr.22306","article-title":"Association of higher methotrexate dose with lymphoproliferative disease onset in rheumatoid arthritis patients","volume":"66","author":"Kameda","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021070122150135400_keab138-B3","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/rheumatology\/ker214","article-title":"Methotrexate-associated lymphoproliferative disorder presenting as disseminated malignancy","volume":"50","author":"Joannides","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"2021070122150135400_keab138-B4","doi-asserted-by":"crossref","first-page":"e1270","DOI":"10.1097\/MD.0000000000001270","article-title":"Primary adrenal lymphoma possibly associated with Epstein-Barr virus reactivation due to immunosuppression under methotrexate therapy","volume":"94","author":"Ohkura","year":"2015","journal-title":"Medicine"},{"key":"2021070122150135400_keab138-B5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3960\/jslrt.19007","article-title":"Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders","volume":"59","author":"Tokuhira","year":"2019","journal-title":"J Clin Exp Hematop"},{"key":"2021070122150135400_keab138-B6","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/rheumatology\/kex002","article-title":"Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate","volume":"56","author":"Saito","year":"2017","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab138\/36226179\/keab138.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/7\/e255\/38850065\/keab138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/7\/e255\/38850065\/keab138.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T22:28:07Z","timestamp":1625178487000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/7\/e255\/6132318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":6,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,2,10]]},"published-print":{"date-parts":[[2021,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab138","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"type":"print","value":"1462-0324"},{"type":"electronic","value":"1462-0332"}],"subject":[],"published-other":{"date-parts":[[2021,7,1]]},"published":{"date-parts":[[2021,2,10]]}}}